Brind.

Patient Capital Management highlighted Tempus AI in its strategy on July 18, 2025.

1 report, 1 independent Updated Jul 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Patient Capital Management highlighted Tempus AI in its strategy on July 18, 2025.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

  • Tempus

    biotechnology company based in Chicago, Illinois

    Nothing else this week.

Related events

Coverage

Newest first; wire copies grouped
  • Insider MonkeyDo You Believe in the Growth Potential of Tempus AI (TEM)? Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” second-quarter 2025 investor